Related Experiment Video
Updated: May 14, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
ULCYP: A Multitask Model for Predicting P450 Inducers Based on Positive-Unlabeled Learning.
Changda Gong1, Jiaojiao Fang1, Guixia Liu1
1Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
ULCYP, a new deep learning model, accurately predicts cytochrome P450 (CYP) induction using limited data. This computational approach aids drug discovery by identifying potential drug-drug interactions and toxicity risks early on.
Area of Science:
- Computational Chemistry
- Drug Discovery
- Machine Learning
Background:
- Predicting cytochrome P450 (CYP) induction is crucial for mitigating drug-drug interactions and toxicity in early drug discovery.
- Limited availability of comprehensive inducer data hinders the development of accurate predictive models for CYP induction.
Purpose of the Study:
- To develop ULCYP, a novel multitask deep learning framework utilizing positive-unlabeled (PU) learning for enhanced CYP induction prediction.
- To leverage large unlabeled datasets to overcome the scarcity of reliable negative samples in CYP induction prediction.
Main Methods:
- Implementation of a multitask deep learning framework (ULCYP) based on positive-unlabeled (PU) learning.
- Utilizing integrated gradients for model interpretability and identifying key molecular substructures.
- Defining a rigorous applicability domain to ensure prediction reliability.
Main Results:
- ULCYP demonstrated superior performance compared to baseline models across multiple metrics.
- Achieved an average area under the curve (AUC) greater than 0.81 on a test set of CYP inducers and nonagonists.
- Successfully predicted induction mediated by key receptors: pregnane X receptor (PXR), constitutive androstane receptor (CAR), and aryl hydrocarbon receptor (AhR).
Conclusions:
- ULCYP effectively addresses data scarcity challenges in CYP induction prediction through PU learning.
- The model provides reliable and interpretable predictions, aiding in the early assessment of drug candidates.
- ULCYP offers a valuable tool for drug discovery, enhancing the prediction of potential drug-drug interactions and toxicity.
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Metabolism: Phase I Reactions
